Skip to main content

and
  1. Article

    Open Access

    Network approach in liquidomics landscape

    Tissue-based biopsy is the present main tool to explore the molecular landscape of cancer, but it also has many limits to be frequently executed, being too invasive with the risk of side effects. These limits ...

    Daniele Santini, Andrea Botticelli in Journal of Experimental & Clinical Cancer … (2023)

  2. No Access

    Article

    A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?

    Skin toxicity in patients affected by metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor (EGFR) inhibitors is well known. However, ad hoc ESMO guidelines have only recently been ...

    Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio in Supportive Care in Cancer (2022)

  3. Article

    Open Access

    High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

    Family history of cancer (FHC) is a hallmark of cancer risk and an independent predictor of outcome, albeit with uncertain biologic foundations. We previously showed that FHC-high patients experienced prolonge...

    Alessio Cortellini, Raffaele Giusti, Marco Filetti in Journal of Hematology & Oncology (2022)

  4. Article

    Open Access

    Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

    Here, we developed an unbiased, functional target-discovery platform to identify immunogenic proteins from primary non-small cell lung cancer (NSCLC) cells that had been induced to apoptosis by cisplatin (CDDP...

    Alessio Grimaldi, Ilenia Cammarata, Carmela Martire in Communications Biology (2020)

  5. Article

    Open Access

    BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors

    Colorectal cancer (CRC) is a heterogeneous disease with a complex biology and a wide number of altered genes such as BRAF, KRAS and PIK3CA. Advances with new-targeted therapies have been achieved and available...

    Evelina Miele, Luana Abballe, Gian Paolo Spinelli, Zein Mersini Besharat in BMC Cancer (2020)

  6. No Access

    Article

    Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy

    Many studies have indicated that the response to therapy and the prognostic impact of a pathologic complete response after neoadjuvant treatment differ among breast cancer subtypes.

    Luigi Rossi, Monica Verrico, Silverio Tomao in Cancer Chemotherapy and Pharmacology (2020)

  7. Article

    Open Access

    Combined surgery and radiotherapy as curative treatment for tracheal adenoid cystic carcinoma: a case report

    Adenoid cystic carcinoma of the trachea is a rare tumor, characterized by slow growth and low rate of local and distant metastasis. When achievable, complete surgical resection represents the optimal treatment...

    Gian Paolo Spinelli, Evelina Miele in Journal of Medical Case Reports (2019)

  8. No Access

    Article

    Correlation between fertility drugs use and malignant melanoma incidence: the state of the art

    The relationship between fertility, reproductive hormones, and risk of malignant melanoma has acquired much interest in recent years. Melanocytes are hormonally responsive cells, and some in vitro studies demonst...

    Federica Tomao, Anselmo Papa, Giuseppe Lo Russo, Sara Zuber in Tumor Biology (2014)

  9. Article

    Open Access

    Fertility drugs, reproductive strategies and ovarian cancer risk

    Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers ...

    Federica Tomao, Giuseppe Lo Russo, Gian Paolo Spinelli in Journal of Ovarian Research (2014)

  10. Article

    Open Access

    Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features

    Extraneural metastases (ENM) rarely occur in medulloblastoma (MBL) patients and only few cases of subcutaneous localizations have been described. ENM indicate an aggressive disease associated with a worse prog...

    Angela Mastronuzzi, Evelina Miele, Agnese Po, Manila Antonelli in BMC Cancer (2014)

  11. Article

    Open Access

    A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report

    Lymphoepithelioma is a very rare form of malignant tumor originating from epithelial line cells. Its occurrence has potential clinical, therapeutic and prognostic implications. In the present report we describ...

    Gian Paolo Spinelli, Giuseppe Lo Russo in Journal of Medical Case Reports (2013)

  12. Article

    Open Access

    Subcutaneous metastases from colon cancer: a case report

    Dukes A stages of colorectal cancer are rarely reported to metastasize. Subcutaneous or skin metastases from colon cancer are rare events and usually indicate widespread disease.

    Giuseppe Lo Russo, Fabio Accarpio, Gian Paolo Spinelli in Journal of Medical Case Reports (2012)

  13. Article

    Open Access

    Breast cancer metastatic to the pituitary gland: a case report

    Metastases to the pituitary gland are rare events, and usually indicate widespread malignant disease. The lung and the breast are the most common sites of primary tumors that metastasize to the pituitary gland.

    Gian Paolo Spinelli, Giuseppe Lo Russo, Evelina Miele in World Journal of Surgical Oncology (2012)

  14. No Access

    Article

    Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy

    The most favourable therapeutic strategy for gastric MALT-lymphoma not responding to Helicobacter pylori eradication still remains unclear, neither official guidelines nor randomised studies being available. We t...

    Angelo Zullo, Cesare Hassan, Alessandro Andriani, Francesca Cristofari in Medical Oncology (2010)

  15. No Access

    Chapter

    Pre-operative Radio-Chemotherapy of Rectal Cancer: Toxicity and Preliminary Results with the Addition of Weekly Oxaliplatin

    The standard pre-operative treatment of rectal cancer consists of radiotherapy combined with continuous infusion of fluorouracil (FU) at a dose of 200 mg/m2/day. Platinum compounds can increase the anti-tumour ac...

    Francesco Dionisi, Daniela Musio in Platinum and Other Heavy Metal Compounds i… (2009)

  16. Article

    Open Access

    The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site

    Esophageal squamous cell carcinoma is a relative common malignancy with a very poor prognosis, even adopting an integrated and multidisciplinary approach. According to the literature, gastrointestinal stromal ...

    Gian Paolo Spinelli, Evelina Miele, Federica Tomao in World Journal of Surgical Oncology (2008)

  17. Article

    Open Access

    Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

    PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physi...

    Evelina Miele, Gian Paolo Spinelli in Journal of Experimental & Clinical Cancer … (2008)

  18. Article

    Open Access

    A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

    Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed an...

    Silverio Tomao, Adriana Romiti, Federica Tomao, Marisa Di Seri in BMC Cancer (2006)